Six neutralizing monoclonal antibodies (MAbs) were used to isolate MAb neutralization-resistant (MAR) mutants from a recent European strain of swine vesicular disease virus (SVDV), ITL/9/93. Sequencing of MAR mutants identified two epitopes located at positions analogous to sites 2A (VP2) and 3B (VP3) on poliovirus (PV) which have been previously identified on a Japanese strain of SVDV. A third epitope near to the C terminus of VP1, not previously recognized on SVDV, was tentatively identified in a region analogous to site 1 of PV. A fourth epitope, located in the C-terminal region of VP3, has never before been recognized as a site of neutralization on picornaviruses. All four epitopes were predicted to be surface-exposed.
Six neutralizing monoclonal antibodies (MAbs) were used to isolate MAb neutralization-resistant (MAR) mutants from a recent European strain of swine vesicular disease virus (SVDV), ITL/9/93. Sequencing of MAR mutants identified two epitopes located at positions analogous to sites 2A (VP2) and 3B (VP3) on poliovirus (PV) which have been previously identified on a Japanese strain of SVDV. A third epitope near to the C terminus of VP1, not previously recognized on SVDV, was tentatively identified in a region analogous to site 1 of PV. A fourth epitope, located in the C-terminal region of VP3, has never before been recognized as a site of neutralization on picornaviruses. All four epitopes were predicted to be surface-exposed.
Swine vesicular disease (SVD) is a highly contagious disease of pigs which was first observed in Italy in 1966 (Nardelli et al., 1968) . Subsequently, outbreaks were seen in Hong Kong in 1971 (Mowat et al., 1972) and in Europe and Japan during 1972 -1975 (Brown et al., 1976 . Following eradication campaigns, SVD was eliminated from most of Europe by the mid 1980s, apart from Italy, where the disease has continued to persist until the present day. Swine vesicular disease has reappeared in Europe, outside Italy, on a number of occasions since 1992 (Knowles & Sellers, 1994 ; Brocchi et al., 1997) . Although SVD is clinically a mild disease, it is nevertheless important as the lesions produced are indistinguishable from those of foot-and-mouth disease (FMD). Consequently, SVD is classified as a list A disease by the Office International des E; pizooties. Kanno et al. (1995) identified five epitopes on the historic Japanese strain of SVD virus (SVDV), H3h76, by analysis of monoclonal antibody (MAb) -resistant (MAR) mutants. Recent strains of SVDV differ significantly from historic strains, such as H3h76, both genetically (Marquardt & Ohlinger, 1995 ; Brocchi et al., 1997) and antigenically (Brocchi et al., 1997) . The Author for correspondence : David Mackay.
Fax j44 1483 232448. e-mail david.mackay!bbsrc.ac.uk study reported here employs techniques similar to those of Kanno et al. (1995) to determine the neutralizing epitopes on a recent European strain of SVDV and uses the MAbs and MAR mutants produced by Kanno et al. (1995) to compare the sites on Japanese and European isolates.
The parental virus used for the current study was a plaquepurified isolate of SVDV ITL\9\93, a strain originally isolated from an outbreak of disease in Forli, Emilia Romagna, Italy during March 1993 (Brocchi et al., 1997) . MAR mutants were selected by mixing 1 ml of virus at 10) TCID &! \ml with 50 µl of ascitic fluid and then inoculating the resulting MAb-virus mixture onto IB-RS-2 cells (De Castro, 1964) . For this and subsequent passages, the culture medium used to sustain presumptive MAR mutants contained a 1 : 50 dilution of the appropriate MAb. If CPE was observed, the supernatant was harvested, mixed again with MAb, and re-inoculated onto IB-RS-2 cells. Presumptive MAR mutants were isolated from any flasks showing CPE by plaque purification and the clones were expanded by two passages in cell culture.
MAR mutants were produced using each of MAbs C29, C70, C74, 5B7, 4H3 and 5D9 and were characterized by virus neutralization (VN) assays (Brown et al., 1976) and by ELISA. The percentage binding of MAbs to MAR mutants in ELISA was expressed as a percentage of the binding to the parental strain using an adaptation of the FMD strain characterization ELISA of Samuel et al. (1991) . All MAR mutants demonstrated loss of reactivity in the VN test against the MAb used to produce them, as exemplified by the MAR mutants whose nucleotide sequences were subsequently determined (Table 1) . With the exception of MAR mutants produced using MAbs 4H3 and 5D9, all mutants also showed loss of reactivity in ELISA with the MAbs used to produce them, whilst binding of all other MAbs was unaffected. Although MAR mutants produced using MAbs 4H3 and 5D9 were not neutralized by their respective MAbs in the VN test, they were still detected by the relevant MAb in ELISA. Similar findings have previously been reported for MAR mutants produced from PV type 1 (Blondel et al., 1986) and FMD virus (McCahon et al., 1989) .
The nucleotide sequences for the externally exposed capsid coding regions of both ITL\9\93 and representative MAR mutants for each MAb were determined by RT-PCR and cycle sequencing using standard techniques (Brocchi et al., 1997 ; Table 1 . Reactivity of MAR mutant viruses with monoclonal antibodies produced against European strains of SVDV Examination by virus neutralization (Brown et al., 1976) and\or ELISA (Samuel et al., 1991) of MAR mutants produced using either ITL\9\93 (upper panel) or H3h76 (lower panel ; Kanno et al., 1995) strains of SVDV, named according to the MAb used to produce them. The single nucleotide substitutions shown for each MAR mutant were detected by comparing the sequence of the mutant with that of the respective parental strain.
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Thr Met * The parental virus, isotype and log "! neutralization index (against ITL\9\93) are as follows : C29, UKG\27\72, IgG2a, 4n2 ; C70, UKG\27\72, IgG2a, 4n5 ; C74, UKG27\72, IgG2a, 4n5; 5B7, R178 (Italy\73), IgG2b, 4n3 ; 4H3, R178 (Italy\73), IgM, 3n9 ; 5D9, R178 (Italy\73), IgM, 3n3.
† Brocchi et al. (1997) . ‡ Log "! neutralization index. § Results given as percentage binding. R Kanno et al. (1995) , MAR mutants and sites named by analogy to PV. Nijhar, 1997 ; data not shown). The parental strain, ITL\9\93, was compared with the MAR mutants in terms of both nucleotide and deduced amino acid sequences (Table 1) . Over the region examined, each MAR mutant had a single nucleotide substitution in the structural protein genes which resulted in an amino acid change. Six MAbs, which recognize five distinct sites on the Japanese SVDV strain H3h76, neutralized ITL\9\93 with neutralization indexes of at least 2n4 log "! (data not shown), suggesting that the epitopes recognized by these MAbs are common to both H3h76 and ITL\9\93. Further evidence of the existence of shared epitopes is provided by the finding that MAbs binding to each of the four distinct epitopes identified in this study neutralized at least four out of the five MAR mutants produced from H3h76 and selected to represent viruses changed at any one of the five sites common to both H3h76 and ITL\9\93 (Table 1) . From this analysis, it appeared that MAb 5B7 recognized the same epitope as MAb 3H02, namely the site analagous to site 2A of PV. Likewise, MAbs 4H3 and 14E10 both recognize site 3B. MAbs C29 and 5D9 bound all Japanese MAR mutants, suggesting that they recognize epitopes distinct from those previously identified on SVDV.
The epitopes identified in this study, together with those previously reported by Kanno et al. (1995) were projected onto the three-dimensional structure of coxsackie virus B3 (CV-B3) (Muckelbauer et al., 1995) using the program RasMol v2.6 (Sayle & Milner-White, 1995) (Fig. 1) . The three-dimensional structure of CV-B3 is likely to be similar to that of SVDV as only two insertion\deletions, involving four amino acids, are required to align the two sequences . A total of nine distinct epitopes have now been identified on the surface of SVDV. All nine epitopes are predicted to be surface-located and seven can be grouped into sites analogous to sites 1, 2 or 3 of PV (Table 2) .
In PV, site 2 is located in the ' puff ' region of VP2, which is a protruding loop between β-sheet E (βE) and α-helix B (αB) and is considered to be a single antigenic site. Kanno et al. (1995) proposed that in SVDV this site comprised two separate antigenic epitopes, sites 2A and 2B, which do not crossneutralize. In this study, the 5B7-1M MAR mutant had a substitution of glutamine to valine at exactly the same residue (163 of VP2) as the 3H02-R1 MAR mutant (Kanno et al., 1995) . Kanno et al. (1995) designated this site 2A to distinguish it from site 2B, which was located at residue 154 of VP2. Site 2B is also located in the ' puff ' region, but is sufficiently distant from site 2A to be a separate site of neutralization. With the exception of the prototype strain of SVDV ITL\1\66, MAb 5B7 reacts with all strains of SVDV against which it has been tested (Brocchi et al., 1997 ; Nijhar, 1997) , suggesting that some epitopes within site 2A are highly conserved between strains of SVDV. For this reason MAb 5B7 is used as the basis of a competition ELISA that is the internationally accepted screening test for antibody to SVDV (Brocchi et al., 1995) . Although SVDV strain ITL\1\66 lacks reactivity with MAb 5B7, sera Kanno et al. (1995) ; (b) this study. Residues involved in neutralizing epitopes identified on SVDV using MAR mutants were mapped onto the three-dimensional structure of CV-B3 (Muckelbauer et al., 1995) using the program RasMol v2.6 (Sayle & Milner-White, 1995) . Epitopes are grouped into sites and named by analogy to PV (Kanno et al., 1995) . The three outer capsid polypeptides are colour-coded blue (VP1), green (VP2) and red (VP3) and the five-, three-and twofold axes of symmetry are indicated.
from pigs infected with this strain give a positive reaction in the 5B7 competition ELISA (Brocchi et al., 1995) , suggesting that the sites of neutralization on SVDV are sufficiently close to each other that blocking occurs, even between two antibodies to different sites. For this reason, it was not possible to characterize the MAbs used in this study using crosscompetition ELISAs, as all MAbs competed with each other to some extent, even those recognizing different sites (Nijhar, 1997) .
MAb 4H3 recognized the site designated 3B, which was also recognized by MAb 23F10 in the study of Kanno et al. (1995) . In both studies there was a substitution of glutamine to arginine at residue 73 of VP3. Site 3B is a complex site involving the βB-βC loop of VP2 and VP3 and the βH-βI loop of VP2. MAb 4H3 binds to all strains of SVDV examined, with the exception of the group of viruses isolated from Italy during the period 1988 -1992 Brocchi et al., 1997) . Therefore, although the 4H3 epitope within site 3B is conserved, stable mutations can arise at this site in the field.
The two remaining epitopes identified by this study have not previously been recognized as sites of neutralization on SVDV. Position 234 of VP3 recognized by MAb 5D9 is located near to the C terminus of VP3. This region has not previously been associated with neutralization in picornaviruses, but its location on the surface of the virion is consistent with access for binding by antibody.
The final epitope identified, residue 261 on VP1, recognized by the C29 group of MAbs, is located between βI and the residues involved in site 3A, which lie close to the C terminus of VP1. The C terminus of VP1 has been identified as a site of neutralization for several picornaviruses ; in PV-3 this area is part of site 3 (Minor et al., 1985 (Minor et al., , 1986 and for human rhinovirus site 14 it is part of site NIm-III (Sherry & Rueckert, 1985) . However, residue 261 is closer to βI than to the C terminus and is predicted to be physically closer to site 1 than to site 3A when mapped onto the three-dimensional structure of CV-B3 (Fig. 1) . Recent evidence from examination of SVDVs recovered late in the course of infection also suggests that residue 261 may be part of site 1. The nucleotide sequences of isolates of SVDV recovered more than 120 days after initial infections were determined (Lin et al., 1998) . Substitutions were identified at amino acid residues 85 and 91 of VP1, which were associated with loss of binding of MAb 4G07, a MAb mapped to site 1 (Kanno et al., 1995) , and of the C29 group of MAbs, respectively (F. Lin, unpublished) . On the predicted three-dimensional structure of SVDV, residues 85, 91 and 261 are located close to each other (Fig. 1) . It seems likely that site 1 of SVDV is composed of at least two distinct neutralizing epitopes, one recognized by MAb 4G07, comprising residues 85, 87 and 88 of VP1 (Kanno et al., 1995 ; Lin et al., 1998) , and the second, recognized by the C29 group of MAbs, comprising residues 91 and 261 of VP1. MAR mutants produced using any of the C29 group of MAbs (MAbs C29, C70 and C74) all had the same amino acid substitution at the same site. The method of production (Butcher et al., 1991) meant that it is possible that these three MAbs are all subclones of a single hybridoma. Finding the same substitution in three individually raised MAR mutants indicates the importance of residue 261 of VP1 in the binding of these MAbs.
MAbs 5B7, 4H3 and 5D9 and the C29 group did not react with any of the capsid proteins of SVDV in immunoblots (data not shown), suggesting that they recognize discontinuous rather than continuous epitopes. Likewise, Kanno et al. (1995) proposed that sites 3A and 3B were discontinuous and involved residues on more than one capsid protein. Although no data were presented, Kanno et al. (1995) stated that at least some of the epitopes on site 1 were continuous, as peptides corresponding to this region induced neutralizing antibodies. If the C29 group of MAbs do recognize an epitope on site 1 then this site must contain both continuous and discontinuous epitopes. It is interesting to note that, in all published reports, MAbs raised against SVDV have recognized discontinuous epitopes (Kanno et al., 1995 ; Brocchi et al., 1997) . The predominance of the immune response in mice to discontinuous rather than continuous epitopes is perhaps surprising as pigs do produce some antibody to continuous epitopes following infection (Tsuda et al., 1987) .
